0208080893 [email protected]
Providers / Bioss Primary Conjugated Antibodies. ALEXA FLUOR / HHV8 ORF50 Antibody, ALEXA FLUOR 555

Description:

Size: 100ul

Catalog no.: bs-0860R-A555

Price: 380 EUR

Get for 380 EUR on Gentaur.com

/ningbo-assets-bio/graphics/prods/bigs/bigs9.jpg

Product details

Modification Site

None

Virus

hhv8

Cross-reactive species details

HHV8

Crossreactivity

Virus

Tested applications

IF(IHC-P)

French translation

anticorps

Target Antigen

HHV8 ORF50

Modification

Unmodified

Clonality

Polyclonal

Immunogen range

650-691/691

Concentration

1ug per 1ul

Excitation emission

553nm/568nm

Conjugated with

ALEXA FLUOR® 555

Recommended dilutions

IF(IHC-P)(1:50-200)

Clone

Polyclonal antibody

Purification

Purified by Protein A.

Conjugation

Alexa Fluor,ALEXA FLUOR 555

Category

Conjugated Primary Antibodies

Host Organism

Rabbit (Oryctolagus cuniculus)

Also known as

Anti-HHV8 ORF50 PAb ALEXA FLUOR 555

Specificity

This is a highly specific antibody against HHV8 ORF50.

Source

KLH conjugated synthetic peptide derived from HHV8/ORF50

Long name

HHV8 ORF50 Polyclonal Antibody, ALEXA FLUOR 555 Conjugated

Synonyms

HHV8 ORF50; HHV 8; Human Herpes Virus 8; Human herpesvirus 8; Kaposi's sarcoma associated herpes virus; Kaposi's sarcoma associated herpesvirus; KSHV.

Storage conditions

Store this antibody in aqueous buffered solution containing 1% BSA, 50% glycerol and 0.09% sodium azide. Keep refrigerated at 2 to 8 degrees Celcius for up to one year.

Properties

For facs or microscopy Alexa 1 conjugate.Very high photo stable ALEXA conjugate.If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies. ALEXA FLUOR they should be stored frozen at - 24°C for long term storage and for short term at + 5°C.

Background of the antigen

HHV8 has been found to be associated with three different diseases observed in AIDS patients; kaposi's sarcoma, primary effusion lymphoma (which is a rare type of non-Hodgkin lymphoma affecting the body cavities) and multicentric Castleman's disease. To date there is much evidence to support a direct role for HHV8 in kaposi's sarcoma.